3The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative north scandinavian enalapril survival study (CONSENSUS). N Engl J Med, 1987,316:1429 - 1435.
4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure) : developed in collaboration with the American college of chest physicians and the international society for heart and lung transplantation: endorsed by the heart rhythm society. Circulation,2005,112 (12) .e154 - e235.
5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005) : The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J,2005,26(11) :1115 - 1140.
6Pfeffer MA, McMurray JJ, Velazquez EJ, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure,left ventricular dysfunction, or both. N Engl J Med,2003,349 (20) :1893 - 1906.
7Granger CB,McMurrary JJ,Yusuf S,et al. Effects of candesartan in patients with chronic heart failure and reduced left - ventricular systolic function intolerant to angiotensin - converting - enzyme inhibitors: the CHARM - Alternative trial. Lancet, 2003,362 (9386) :772 - 776.
8Cohn JN,Tognoni G, Valsartan Heart Failure Trail Investigators. A randomized trial of theangiotensin - receptor blocker valsartan in chronic heart failure. N Engl J Med, 2001,345 (23) : 1667 - 1675.
9Pitt B,Segal R, Martiniez FA, et al. Randomized trial of losartan versus capital in patients over 65 with heart failure. Lancet, 1997,349(9054) : 747 - 755.
10Pitt B, Poole-Wilson PA,Segal R,et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure:randomised trial:the losartan heart failure survival study ELITE Ⅱ. Lancet, 2000, 355 (9215):1582-1587.
